{
    "root": "30c7bba4-3080-305f-e063-6394a90aea6e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Captopril",
    "value": "20250320",
    "ingredients": [
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "STEARIC ACID",
            "code": "4ELV7Z65AP"
        },
        {
            "name": "CAPTOPRIL",
            "code": "9G64RSX1XD"
        }
    ],
    "indications": null,
    "contraindications": "Captopril tablets should be taken one hour before meals. Dosage must be individualized.",
    "warningsAndPrecautions": "Captopril Tablets, USP are available as follows:\n                  25 mg - White, Round Tablets; Debossed \"WW 172\" on one side and Quadrisect Scored on the other side.\n                              Bottles of 30 tablets                                    NDC 55289-344-30\n                              Bottles of 90 tablets                                    NDC 55289-344-90\n                  All Captopril Tablets, USP are white and may exhibit a slight sulfurous odor.\n                  Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature].\n                  Keep bottles tightly closed (protect from moisture).\n                  Dispense in a tight, light-resistant container as defined in the USP using a child-resistant closure.",
    "adverseReactions": "Captopril tablets are contraindicated in patients who are hypersensitive to this product or any other angiotensin-converting enzyme inhibitor (e.g., a patient who has experienced angioedema during therapy with any other ACE inhibitor).\n                  Do not co-administer aliskiren with captopril tablets in patients with diabetes (see\n \n  \n                        PRECAUTIONS, Drug Interactions\n                     ).\n\n \n                  Captopril tablets are contraindicated in combination with a neprilysin inhibitor (e.g., sacubitril). Do not administer captopril tablets within 36 hours of switching to or from sacubitril/valsartan, a neprilysin inhibitor (see\n \n  \n                        PRECAUTIONS, Drug Interactions\n                     )."
}